1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow dipeptidase 1: new trials by email Literature Review of dipeptidase 1 trials Research Report on dipeptidase 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity MOTS-c (MDP), Placebo, Route Subcutaneous injection - Prediabetes, Insulin Resistance | Phase 2 | Recruiting | Hudson Biotech | 120 | 2026-02-02 | 2026-04-01 |
| Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma incomplete Freund's adjuvant, melanoma helper peptide vaccine, multi-epitope melanoma peptide vaccine - Melanoma (Skin) | Phase 2 | Completed | Eastern Cooperative Oncology Group | 175 | 2005-05-09 | 2023-06-28 |
Insulin Resistance (1) · Melanoma (1) · Metabolic Syndrome (1) · Obesity (1) · Overweight (1) · Prediabetic State (1)
Eastern Cooperative Oncology Group (1) · Hudson Biotech (1)
China (1) · United States (1)
U10CA021115 (1)